ASSET PURCHASE AGREEMENT by and between CytRx Corporation, as Seller, and Orphazyme ApS, as Buyer May 13, 2011Asset Purchase Agreement • August 9th, 2011 • Cytrx Corp • Biological products, (no disgnostic substances) • Delaware
Contract Type FiledAugust 9th, 2011 Company Industry JurisdictionThis Asset Purchase Agreement (this “Agreement”) is made as of May 13, 2011, by and between CytRx Corporation, a Delaware corporation (“Seller”), and Orphazyme ApS, a company organized under the laws of Denmark (“Buyer”). Seller and Buyer are each referred to individually as a “Party” and collectively as the “Parties.”